Welcome to our dedicated page for Ufp Technologies news (Ticker: UFPT), a resource for investors and traders seeking the latest updates and insights on Ufp Technologies stock.
UFP Technologies, Inc. (UFPT) is a Nasdaq-listed contract development and manufacturing organization focused on single-use and single-patient medical devices. Its news flow centers on financial performance, strategic acquisitions, facility expansions, leadership updates, and investor outreach, all within the context of the medical device and advanced manufacturing sectors.
Investors following UFPT news can expect regular earnings releases detailing quarterly and year-to-date results, including net sales, profitability metrics, and non-GAAP measures such as organic sales growth, adjusted operating income, adjusted net income, and adjusted EBITDA. These releases are typically accompanied by conference call announcements and webcast information, giving additional context on trends in the company’s MedTech and non-medical businesses, gross margins, and SG&A spending.
Company news also highlights strategic moves such as the acquisitions of Universal Plastics & Engineering Company, Inc. (UNIPEC) and Techno Plastics Industries, Inc. (TPI), which expand UFP Technologies’ capabilities in tight-tolerance film components and thermoplastic molding for the medical device market. Updates on expansion projects in locations such as Santiago and La Romana in the Dominican Republic, and commentary on programs in safe patient handling and robotic-assisted surgery drape solutions, appear in these communications.
In addition, UFPT issues press releases about participation in investor conferences, updated investor presentation materials, and governance developments such as its CEO succession plan. The UFPT news page aggregates these items so readers can review financial updates, acquisition announcements, operational developments, and leadership changes in one place.
UFP Technologies (NASDAQ:UFPT) has acquired Universal Plastics & Engineering Company (UNIPEC), a Maryland-based manufacturer of precision thermoformed and heat-sealed polymer components for medical devices. UNIPEC specializes in producing components for battery shielding in Class III implantable medical devices.
The acquisition strengthens UFP Technologies' presence in the medical manufacturing sector. UNIPEC, a family-owned business since 1957, brings valuable capabilities and customer relationships to UFP's expanding medical-focused portfolio. Trout Capital Advisors served as the exclusive financial advisor to UNIPEC in this transaction.
UFP Technologies (NASDAQ:UFPT) has announced two strategic acquisitions to enhance its medical device manufacturing capabilities: Universal Plastics & Engineering Company (UNIPEC) and Techno Plastics Industries (TPI).
UNIPEC, based in Maryland, specializes in precision thermoformed and heat-sealed polymer components for Class III implantable medical devices, with $5 million in revenue and $2 million in EBITDA. TPI, located in Puerto Rico, focuses on precision thermoplastic injection-molded components, generating $10 million in revenue and $1 million in EBITDA.
The acquisitions strengthen UFP's capabilities in tight tolerance film components and thermoplastic molding, particularly complementing their Welch Fluorocarbon operation and DAS business in the Dominican Republic. The deals were funded through available cash and existing credit facilities.
UFP Technologies (NASDAQ:UFPT) has announced its participation in the CJS Securities 25th Annual Summer Conference. Mitchell Rock, President, and Ron Lataille, Senior Vice President & CFO, will deliver a presentation and conduct one-on-one investor meetings at the event scheduled for Thursday, July 10, 2025.
UFP Technologies (NASDAQ: UFPT), a designer and manufacturer of medical device components and sterile packaging solutions, has scheduled its first quarter 2025 financial results announcement for May 6, 2025, before market opening.
The company will host a conference call at 10:00 AM Eastern Time on the same day to discuss the Q1 2025 results. Investors can join through:
- Toll-Free: 1-888-243-4451
- International: 1-412-542-4135
A live webcast will be available at www.ufpt.com, with a replay accessible afterward on the company's Investor Relations website at ufpt.com/investors/.
UFP Technologies (Nasdaq: UFPT), a specialized manufacturer focusing on medical market components and packaging, has announced its participation in the upcoming KeyBanc Capital Markets Healthcare Forum. The virtual event will feature presentations from the company's leadership, including Chairman and CEO R. Jeffrey Bailly and CFO Ron Lataille, scheduled for March 18, 2025, at 10:30 AM ET.
UFP Technologies (UFPT) reported record financial results for 2024, with net income rising 31.3% to $59.0 million and adjusted net income growing 32.5% to $67.6 million. Net sales increased 26.1% to $504.4 million compared to $400.1 million in 2023.
For Q4 2024, the company reported net income of $16.4 million (up 41.1%) and sales of $144.1 million (up 41.9%) compared to the same period in 2023. The company's MedTech segment showed particularly strong growth, with Q4 sales increasing 48.6% to $132.7 million and full-year sales rising 30.2% to $450.8 million.
CEO R. Jeffrey Bailly highlighted strong performance from newly acquired companies and noted expansion of operations in the Dominican Republic to accommodate business growth. The company anticipates two major programs launching in the second half of 2025 and expects strong cash flow to help reduce debt and position for future acquisitions.
UFP Technologies (Nasdaq: UFPT), a specialized manufacturer focusing on medical devices, sterile packaging, and engineered custom products, has announced its upcoming financial disclosure schedule. The company will release its fourth quarter and year-end 2024 financial results on Tuesday, February 25, 2025. This announcement pertains to the financial period ending December 31, 2024.